JAKARTA - Argentina has signed a contract with drug manufacturer AstraZeneca to bring in around 22 million doses of the COVID-19 vaccine, which is being developed with the University of Oxford. The first deliveries are scheduled for the first half of next year.
AstraZeneca, one of a number of companies around the world that is developing a vaccine to fight the coronavirus, said in a statement circulated by the government on Saturday that the schedule for the first shipment was dependent on successful trials and regulatory approval.
Argentina, which is starting to see COVID-19 cases in the country rampant, hopes to receive about 10 million doses of the Russian-made Sputnik V vaccine and smaller doses of Pfizer's vaccine between December and January.
Argentina is also feeling the devastating shock of the COVID-19 pandemic, despite implementing a tight lockdown in March. To date, Argentina has recorded 1.23 million cases of COVID-19 with 33,136 deaths.
Regulators have yet to approve of the COVID-19 vaccine, but large-scale trials are ongoing and initial results are expected in November-December.
Argentina is currently helping to produce the AstraZeneca-Oxford vaccine for the Latin American region.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
Most Popular Tags
#Prabowo Subianto #golkar #OTT KPK #Pilkada Dki #online gamblingPopular
